The Immune Response to Cancer Diagnostics
HalioDx is an immuno-oncology diagnostic company providing oncologists with first-in-class Immune-based diagnostic products and services to guide cancer care and contribute to precision medicine in the era of immuno-oncology and combination therapies.
HalioDx has a panel of proprietary tests available, including Immunoscore®, Halioseek® and Immunosign®; and capabilities to develop solutions based on every technologies (notably IHC, PCR, NGS).
HalioDx collaborates with renowned international clinical groups to support clinical utility and to ensure rigorous performance in validation of its assays in selected cancer indications. The company also works with many pharmaceutical and biotech companies to support the clinical development of their innovative drug candidates.
With a CLIA laboratory certified in 2017, facilities compliant with the requirements of in vitro diagnostics, a testing laboratory and a suitable quality system, HalioDx is located in Marseille, France.
Created in 2015, the company already relies on a team of more than 130 employees motivated and passionate about making it their mission to help cancer patients through diagnostic innovation.
At HalioDx, we value our employees and consider them an integral part of our company’s growth and success. Our employees are our most valuable asset, and the individual perspectives and contributions of each person on our team are essential to our success. We place great importance on ensuring that their working environment fosters team spirit, promotes training and offers career development opportunities in France and the United States.
At HalioDx, you have the unique opportunity to make a difference in the lives of patients while developing your career potential. Join our team and participate in the fight against cancer!
For more information, please visit our websites www.haliodx.com, www.immunoscore-colon.com and www.halioseek.com and follow the company on Twitter @HalioDx.
